Rankings
▼
Calendar
CAMP Q1 2018 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$126M
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$94M
+9.6% YoY
Gross Profit
$38M
40.7% margin
Operating Income
$2M
2.1% margin
Net Income
-$5M
-5.1% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
+0.8%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$6M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$473M
Total Liabilities
$274M
Stockholders' Equity
$199M
Cash & Equivalents
$133M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$94M
$86M
+9.6%
Gross Profit
$38M
$36M
+7.4%
Operating Income
$2M
-$2M
+183.8%
Net Income
-$5M
-$3M
-36.7%
Revenue Segments
Telematics Systems
$78M
83%
Software And Subscription Services
$16M
17%
Geographic Segments
UNITED STATES
$68M
69%
Europe Middle East And Africa
$12M
12%
South America
$12M
12%
Asia Pacific
$3M
3%
CANADA
$3M
3%
← FY 2018
All Quarters
Q2 2018 →